According to SPER Market Research, the Stem Cell Therapy Market estimated to reach USD 700.19 million by 2030 with a CAGR of 15.8%.
Stem cells have the ability to build every tissue in the human body, thus have enormous potential for future therapeutic uses in tissue regeneration and repair. There are two types of stem cells: pluripotent and multipotent cells.
Increasing stem cell research and GMP-certified facilities to manufacture stem cells, rising demand for induced pluripotent stem cells, increasing clinical trials for stem cell based-therapies; are the key factors for the escalation of the market.
Costly cell-based research, ethical concerns related to embryonic stem cells; are the restraint to the expansion of the market.
On the increase in the demand for cell & gene therapies, the emergence of induced pluripotent stem cells alternative to embryonic stem cells; provide huge opportunities for the players in the market.
The allogeneic stem cell therapy segment, the Inflammatory & autoimmune diseases segment from the Type segment, Therapeutic segment respectively dominated the Stem Cell Therapy Market.
The rising number of biobanks, research centers, funding for research, increase research activities, are the key factors for the expansion of the market in Asia Pacific.
North America dominated the principal share of this Stem Cell Therapy Market; this is because of increasing figure of clinical trials, growing public-private partnership funding, research grants to develop safe & effective stem cell therapy products.
The global Stem Cell Therapy Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; AlloSource, Anterogen, BioRestorative Therapies, BrainStorm Cell Therapeutics, Cellular Biomedicine Group, CORESTEM, Holostem Terapie Avanzate S.r.l, Hope Biosciences, JCR Pharmaceuticals, Kangstem Biotech, MEDIPOST, Mesoblast, NuVasive, Orthofix, Personalized Stem Cells, PHARMICELL, Pluristem Therapeutics, Regrow Biosciences, RTI Surgical, Smith & Nephew Stempeutics Research, Under Pipeline Athersys, Takeda Pharmaceutical Company, ViaCyte.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Type segment- Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy; for Cell Source segment- Adipose tissue-derived MSCs (mesenchymal stem cells), Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, and Other Cell Sources; for Therapeutic Application segment- Cardiovascular Diseases, Inflammatory & Autoimmune Diseases, Musculoskeletal Disorders, Neurological Disorders, Surgeries, Wounds & Injuries, Other Therapeutic Applications.
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.